Covered recipient · General Payments record
ELLEN S LI
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2025
$425.62
- Reported across 14 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $325.62 | 13 |
| Education | $100.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Madrigal Pharmaceuticals | $100.01 | 3 |
| INTUITIVE SURGICAL, INC. | $100.00 | 1 |
| Lilly USA, LLC | $39.51 | 2 |
| ARGENX US, INC. | $35.95 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.32 | 1 |
| Medtronic, Inc. | $25.80 | 1 |
| Sequel Med Tech, LLC | $22.50 | 1 |
| UCB, Inc. | $20.08 | 1 |
| Ardelyx, Inc. | $18.91 | 1 |
| EVOKE PHARMA, INC. | $15.38 | 1 |
| Novo Nordisk AS | $15.16 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $425.62 | 14 |
Payment records · PY2025 (14)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ardelyx, Inc. | $18.91 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247925661 | CMS |
| ARGENX US, INC. | $35.95 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240450669 | CMS |
| EVOKE PHARMA, INC. | $15.38 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243916569 | CMS |
| INTUITIVE SURGICAL, INC. | $100.00 | 02/05/2025 | Education | Undisputed | 06/30/2026 | 1236525344 | CMS |
| Lilly USA, LLC | $17.45 | 02/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187127225 | CMS |
| Lilly USA, LLC | $22.06 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187040867 | CMS |
| Madrigal Pharmaceuticals | $24.92 | 03/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248360941 | CMS |
| Madrigal Pharmaceuticals | $28.69 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248360943 | CMS |
| Madrigal Pharmaceuticals | $46.40 | 10/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248360945 | CMS |
| Medtronic, Inc. | $25.80 | 01/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219791853 | CMS |
| Novo Nordisk Inc | $15.16 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188250431 | CMS |
| Sequel Med Tech, LLC | $22.50 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243768120 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.32 | 09/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224085966 | CMS |
| UCB, Inc. | $20.08 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1224388450 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.